Literature DB >> 28478862

Symptoms and health-related quality of life in patients with advanced cancer - A population-based study in Greenland.

Mikaela Augustussen1, Per Sjøgren2, Helle Timm3, Lise Hounsgaard4, Michael Lynge Pedersen5.   

Abstract

PURPOSE: The aims were to describe symptoms and health-related quality of life (HRQoL) in Greenlandic patients with advanced cancer and to assess the applicability and internal consistency of the Greenlandic version of the EORTC-QLQ-C30 core version 3.0.
METHODS: A Greenlandic version of the EORTC QLQ-C30 v.3.0 was developed. The translation process included independent forward translation, reconciliation and independent back translation by native Greenlandic-speaking translators who were fluent in English. After pilot testing, a population-based cross-sectional study of patients with advanced cancer receiving palliative treatment was conducted. Internal consistency was examined by calculating Cronbach's alpha coefficients for five function scales and three symptom scales.
RESULTS: Of the 58 patients who participated in the study, 47% had reduced social functioning, 36% had reduced physical and role functioning and 19% had reduced emotional and cognitive functioning. Furthermore, 48% reported fatigue, and 33% reported financial problems. The Greenlandic version of the EORTC had good applicability in the assessment of symptoms and quality of life. Acceptable Cronbach's alpha coefficients (above 0.70) were observed for the physical, role and social functioning scales, the fatigue scale and the global health status scale.
CONCLUSIONS: Patients with undergoing palliative treatment in Greenland for advanced cancer reported high levels of social and financial problems and reduced physical functioning. This indicates a potential for improving palliative care service and increasing the focus on symptom management. The Greenlandic version of the EORTC-QLQ-C30 represents an applicable and reliable tool to describe symptoms and health-related quality of life among Greenlandic patients with advanced cancer.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Advanced cancer; EORTC QLQ-C30; Greenlandic; Quality of life; Translation

Mesh:

Year:  2017        PMID: 28478862     DOI: 10.1016/j.ejon.2017.03.004

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  5 in total

1.  Functional impairment, symptom severity, and overall quality of life in patients with advanced lung or colorectal cancer in six European countries: baseline findings from the ACTION study.

Authors:  Mariëtte N Verkissen; Aline De Vleminck; Mogens Groenvold; Lea J Jabbarian; Francesco Bulli; Wilfried Cools; Johannes J M van Delden; Urška Lunder; Guido Miccinesi; Sheila A Payne; Kristian Pollock; Judith A C Rietjens; Luc Deliens
Journal:  Support Care Cancer       Date:  2021-03-19       Impact factor: 3.603

2.  Determinants of health-related quality of life in Iranian adults: evidence from a cross-sectional study.

Authors:  Satar Rezaei; Mohammad Hajizadeh; Ali Kazemi; Masoud Khosravipour; Farid Khosravi; Shahab Rezaeian
Journal:  Epidemiol Health       Date:  2017-08-15

3.  Development of health-related quality of life and symptoms in patients with advanced cancer in Greenland.

Authors:  M Augustussen; M L Pedersen; L Hounsgaard; H Timm; P Sjøgren
Journal:  Eur J Cancer Care (Engl)       Date:  2018-03-26       Impact factor: 2.520

4.  What Explains Socioeconomic Inequality in Health-related Quality of Life in Iran? A Blinder-Oaxaca Decomposition.

Authors:  Satar Rezaei; Mohammad Hajizadeh; Yahya Salimi; Ghobad Moradi; Bijan Nouri
Journal:  J Prev Med Public Health       Date:  2018-08-07

5.  Psychoeducational Nursing Intervention for Symptom Management in Cancer Patients: A Randomized Clinical Trial.

Authors:  Marina de Góes Salvetti; Suzana Cristina Teixeira Donato; Caroline Silva Pereira Machado; Natalia Gondim de Almeida; Daniela Vivas Dos Santos; Geana Paula Kurita
Journal:  Asia Pac J Oncol Nurs       Date:  2021-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.